• Skip to main content
  • Skip to footer

Delphi Diagnostics

Delphi Diagnostics guides personalized breast cancer therapy decisions with SET.

  • Our Technology
    • Lead Inventor
    • Breast Cancer Diagnostic Tests
    • Intellectual Property
  • Our Mission
  • Our Company
    • Board of Directors
    • Executive Team
    • Advisory Board
    • Trusted Collaborators
  • News
  • Contact Us
Home » Our Company

Our Company

Delphi Diagnostics Inc.TM is a Texas-based start-up, incorporated in 2016, with an exclusive license to intellectual property from Dr. Fraser Symmans’ breast cancer research at the University of Texas MD Anderson Cancer Center in Houston.

Delphi’s team of professionals brings extensive experience in developing and validating diagnostics from the laboratory to the patient. The company’s first pipeline diagnostic will be SETTM for hormone receptor-positive breast cancer.

Learn More about SETTM

Footer

Join us on:

  • LinkedIn
  • Privacy Policy
  • Contact Us
  • News

Copyright © 2023 · Delphi Diagnostics, Inc.™ All rights reserved.